JLE

European Journal of Dermatology

MENU

Pyoderma gangrenosum possibly triggered by adalimumab Volume 22, issue 6, November-December 2012

Figures

See all figures

Authors
Department of Dermatology, Fukushima Medical University, Fukushima 960-1295, Japan

ejd.2012.1849 Auteur(s) : Nobuyuki Kikuchi nobuyuk@fmu.ac.jp, Tomoko Hiraiwa, Takenobu Ohashi, Yuka Hanami, Masataka Satoh, Hideo Takenoshita, Toshiyuki Yamamoto Department of Dermatology, Fukushima Medical University, Fukushima 960-1295, Japan Therapies for pyoderma gangrenosum (PG) include glucocorticosteroids, steroid-sparing immunosuppressive agents, immunomodulators, antimicrobial agents, intravenous immunoglobulin, and granulocyte apheresis [1, 2]. Recently, several papers have shown [...]